Patrick Lamy

Insider Reports History

Entity
Individual
Location
Akero Therapeutics, Inc., 601 Gateway Boulevard, Suite 350, South San Francisco, CA
Signature
/s/ Jonathan Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick Lamy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Senior VP, Commercial Strategy Common Stock 18.8K $375K $19.94 Jun 28, 2024 Direct
Akero Therapeutics, Inc. Senior VP, Commercial Strategy Stock Option (Right to Buy) 83.6K Dec 8, 2023 Direct

Insider Reports Filed by Patrick Lamy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKRO Akero Therapeutics, Inc. Jun 28, 2024 1 $4.41K 4 Jul 2, 2024 Senior VP, Commercial Strategy
AKRO Akero Therapeutics, Inc. Jun 11, 2024 1 -$12.9K 4 Jun 13, 2024 Senior VP, Commercial Strategy
AKRO Akero Therapeutics, Inc. Dec 8, 2023 2 $0 4 Dec 12, 2023 Senior Vice President, Commercial Strategy
AKRO Akero Therapeutics, Inc. Jan 10, 2023 1 $0 4 Jan 11, 2023 Senior Vice President, Commercial Strategy
AKRO Akero Therapeutics, Inc. Jan 10, 2023 0 $0 3 Jan 11, 2023 Exhibit 24: Power of Attorney Senior Vice President, Commercial Strategy